Challenges in psychopharmacology: a drug information centre perspective

Journal of Clinical Pharmacy and Therapeutics
Jan Schjøtt

Abstract

Questions about psychotropic drugs are frequently submitted to drug information centres (DICs). Twenty years' experience from Norwegian DICs was used to identify particular challenges in responding to those questions. Questions about psychopharmacological therapy are usually patient-related and are often difficult to answer. Frequent questions about psychotropic drugs come from experienced senior physicians in disciplines like psychiatry, geriatrics, general practice and neurology. The physicians often ask about specific drug use in pregnancy or breastfeeding, drug combinations and interactions, drug switching and formulations, and drug-withdrawal reactions. There is a lack of relevant information in drug monographs and guidelines to inform answers to the questions posed for the care of individual patients. There is a clear need for these topics to be highlighted in the pre- and postgraduate teaching of physicians. The issues highlighted are likely to be of international relevance based on our experience of the use of international sources of drug information.

References

Jan 1, 1992·European Journal of Clinical Pharmacology·B OhmanF Sjöqvist
Apr 9, 2002·European Journal of Clinical Pharmacology·Jan SchjøttAne Gedde-Dahl
Apr 22, 2004·Journal of the American Pharmacists Association : JAPhA·Jacob AbarcaRichard B Lipton
Aug 19, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sofia K Frost Widnes, Jan Schjøtt
Dec 5, 2008·European Journal of Clinical Pharmacology·Sofia Kristina Frost Widnes, Jan Schjøtt
Jan 13, 2009·European Journal of Clinical Pharmacology·U Hedegaard, P Damkier
May 28, 2010·The British Journal of Psychiatry. Supplement·David Taylor
Feb 3, 2012·Current Women's Health Reviews·Jan Øystein Berle, Olav Spigset
Mar 30, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sofia Frost WidnesAnne Gerd Granas
May 10, 2013·European Journal of Clinical Pharmacology·Gunnar AlvánElisabeth Törnqvist
May 18, 2013·BMC Medicine·Uzoezi OzomaroCharles B Nemeroff
Mar 13, 2014·Swiss Medical Weekly·Chantal CsajkaAlice Panchaud
Apr 10, 2015·Evidence-based Mental Health·Enrico G Castillo, T Scott Stroup
May 28, 2015·The New England Journal of Medicine·J Larry Jameson, Dan L Longo

❮ Previous
Next ❯

Citations

Feb 3, 2019·Journal of Clinical Pharmacy and Therapeutics·Jan Schjøtt, Olav Spigset
Jul 17, 2019·Basic & Clinical Pharmacology & Toxicology·Carina Tukukino, Susanna M Wallerstedt
Jun 5, 2019·Journal of Psychosocial Nursing and Mental Health Services·Barbara J Limandri

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Semaine des hôpitaux. Therapeutique
A J Charles-Nicolas, F Caroli
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis
J P Junod
Therapeutische Umschau. Revue thérapeutique
H Walther-Büel
Wiener medizinische Wochenschrift
G Hebenstreit
© 2022 Meta ULC. All rights reserved